BioSpace News Archive

Company’s growth supports upcoming clinical programs to help better predict patient response to oncology drugs before treatment begins

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for XALKORI® (crizotinib) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with MET exon 14 alterations with disease progression on or after platinum-based chemotherapy.

Tarveda Therapeutics, Inc. today announced that Drew Fromkin, President and Chief Executive Officer, will present at the 2018 BIO International Convention.

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Commission (EC) has authorized Rubraca (rucaparib) as monotherapy treatment of adult patients with platinum-sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer.

The Partnership for Drug-Free Kids has named Rachel Chernick, LCSW as Director of Clinical Research.

908 Devices announced the recent appointment of Nicolas Barthelemy to its Board of Directors.

The Civica Group has announced that Civica UK Limited, the company’s wholly owned subsidiary, has acquired master data management company VisionWare Limited.

The California State University Institute for Palliative Care has announced the keynote speakers headlining this year’s National Symposium for Academic Palliative Care Education and Research.

Points Group and PatientTrak a leader in patient satisfaction solutions, have announced a partnership between the two companies.

World No Tobacco Day is a World Health Organization initiative that will be held on 31 May and this year will focus on raising awareness of the link between tobacco and cardiovascular disease (CVD).